JASPER THERAPEUTICS INC - COM (JSPR)

CUSIP: 471871103

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
93,692,255
Share change
+79,073,323
Total reported value
$168,805,066
Put/Call ratio
50%
Price per share
$1.81
Number of holders
45
Value change
+$142,866,970
Number of buys
41
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 471871103?
CUSIP 471871103 identifies JSPR - JASPER THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of JASPER THERAPEUTICS INC - COM (JSPR) as of Q1 2023

As of 31 Mar 2023, JASPER THERAPEUTICS INC - COM (JSPR) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,692,255 shares. The largest 10 holders included Velan Capital Investment Management LP, BVF INC/IL, Carlyle Group Inc., Qiming U.S. Ventures Management, LLC, Soleus Capital Management, L.P., Octagon Capital Advisors LP, FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., CITADEL ADVISORS LLC, and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.